The dysfunction of hypothalamic–pituitary–adrenal (HPA) axis, the increased secretion of corticotropin-releasing hormone (CRH), the impaired responsiveness to glucocorticoids, the increased size and activity of the pituitary were found in patients in depression patients. This evidence concerns the gene CRH and depressive symptom measurement.